Putnam Investments LLC Veru Inc. Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $29,239 - $67,805	2,861 Added 9.54%	32,845 $378,000
Q2 2022 Aug 15, 2022	SELL	$4.35 - $15.85 $243,813 - $888,376	-56,049 Reduced 65.15%	29,984 $339,000
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $17,367 - $24,466	3,817 Added 4.64%	86,033 $416,000
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $484,252 - $799,961	82,216 New	82,216 $484,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.